What Happened? Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) jumped 4.6% in the morning ...

On October 17, 2025, Capricorn Fund Managers Ltd disclosed a new stake in Ionis Pharmaceuticals, acquiring approximately ...

One thing that stands out about Recursion right away is how the company refers to itself. Recursion doesn't say that it's a pharmaceutical, biopharmaceutical, or biotech company. Instead, it uses the ...

AbbVie is a sector mainstay that had no fewer than 12 drugs with net sales above $1 billion last year. It also paid a generous dividend. Some pharmaceutical companies dream of developing and launching ...

In the last three months, 22 analysts have published ratings on Ionis Pharmaceuticals (NASDAQ:IONS), offering a diverse range of perspectives from bullish to bearish. The following table provides a ...

Some pharmaceutical companies dream of developing and launching one blockbuster drug that will sustain it. Going by full-year 2024 sales, AbbVie had no fewer than 12 of them, a lineup that includes ...